Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00300404
What this trial is testing

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Who this might be right for
SchizophreniaMajor Depression
Zentrum für Integrative Psychiatrie 40
Large-scale testing (Phase 3)Ended earlyNCT02435836
What this trial is testing

A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 631
Not applicableUnknownNCT03862209
What this trial is testing

Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia

Who this might be right for
Severe Mental DisorderSchizophreniaBipolar Disorder+1 more
Klinički Bolnički Centar Zagreb 200
Large-scale testing (Phase 3)Study completedNCT00145444
What this trial is testing

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 100
Not applicableStudy completedNCT02627716
What this trial is testing

Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective Disorder

Who this might be right for
Schizophrenia
University Hospital, Lille 124
Testing effectiveness (Phase 2)Study completedNCT00482430
What this trial is testing

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)

Who this might be right for
Paranoid SchizophreniaSchizophrenia
Merck Sharp & Dohme LLC 50
Post-approval studies (Phase 4)WithdrawnNCT00672464
What this trial is testing

Cardio Risk of Acute Schizophrenia Olanzapine Duke

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University
Post-approval studies (Phase 4)UnknownNCT02935998
What this trial is testing

The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

Who this might be right for
Schizophrenia
Yang Fude 1,000
Not applicableLooking for participantsNCT07091344
What this trial is testing

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Who this might be right for
Schizophrenia DisordersTreatment Resistant Hallucinations
Fundació Sant Joan de Déu 30
Large-scale testing (Phase 3)WithdrawnNCT00534898
What this trial is testing

Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderCognition
Beersheva Mental Health Center
Not applicableStudy completedNCT00047450
What this trial is testing

Antidepressant Treatment in Older Adults With Schizophrenia

Who this might be right for
Schizophrenia
Veterans Medical Research Foundation 212
Post-approval studies (Phase 4)Ended earlyNCT03643159
What this trial is testing

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Who this might be right for
SchizophreniaBipolar 1 DisorderMajor Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 2
Post-approval studies (Phase 4)Study completedNCT00215579
What this trial is testing

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University 64
Large-scale testing (Phase 3)Study completedNCT01942148
What this trial is testing

A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT00308997
What this trial is testing

Transcranial Magnetic Stimulation for "Voices"

Who this might be right for
SchizophreniaHallucinations
Yale University 85
Large-scale testing (Phase 3)Study completedNCT00090324
What this trial is testing

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 249
Large-scale testing (Phase 3)Study completedNCT00292409
What this trial is testing

Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

Who this might be right for
Schizophrenia and Schizoaffective Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 400
Large-scale testing (Phase 3)Study completedNCT03955549
What this trial is testing

Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial

Who this might be right for
Schizophrenia Spectrum and Other Psychotic Disorders
Agiad Psychiatry Hospital 99
Large-scale testing (Phase 3)Ended earlyNCT00148590
What this trial is testing

Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
M. Schaefer, MD 24
Not applicableLooking for participantsNCT07818668
What this trial is testing

TACS for Self-Other Boundary in Schizophrenia

Who this might be right for
Schizophrenia / Schizoaffective Disorder
Chunyan Zhu 100
Next Page